172 related articles for article (PubMed ID: 24026240)
1. Providing guidance in the dark: rare renal diseases and the challenge to improve the quality of evidence.
Bolignano D; Nagler EV; Van Biesen W; Zoccali C
Nephrol Dial Transplant; 2014 Sep; 29(9):1628-32. PubMed ID: 24026240
[TBL] [Abstract][Full Text] [Related]
2. Good-quality research in rare diseases: trials and tribulations.
Bolignano D; Pisano A
Pediatr Nephrol; 2016 Nov; 31(11):2017-23. PubMed ID: 26817476
[TBL] [Abstract][Full Text] [Related]
3. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
Parker S
Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
[TBL] [Abstract][Full Text] [Related]
4. Orphan kidney diseases.
Soliman NA
Nephron Clin Pract; 2012; 120(4):c194-9. PubMed ID: 22922418
[TBL] [Abstract][Full Text] [Related]
5. Alternative designs for clinical trials in rare diseases.
Abrahamyan L; Feldman BM; Tomlinson G; Faughnan ME; Johnson SR; Diamond IR; Gupta S
Am J Med Genet C Semin Med Genet; 2016 Dec; 172(4):313-331. PubMed ID: 27862920
[TBL] [Abstract][Full Text] [Related]
6. A systematic literature review of evidence-based clinical practice for rare diseases: what are the perceived and real barriers for improving the evidence and how can they be overcome?
Rath A; Salamon V; Peixoto S; Hivert V; Laville M; Segrestin B; Neugebauer EAM; Eikermann M; Bertele V; Garattini S; Wetterslev J; Banzi R; Jakobsen JC; Djurisic S; Kubiak C; Demotes-Mainard J; Gluud C
Trials; 2017 Nov; 18(1):556. PubMed ID: 29166947
[TBL] [Abstract][Full Text] [Related]
7. Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data.
Groft SC; Posada de la Paz M
Adv Exp Med Biol; 2017; 1031():3-21. PubMed ID: 29214563
[TBL] [Abstract][Full Text] [Related]
8. A new toolkit for conducting clinical trials in rare disorders.
Abrahamyan L; Diamond IR; Johnson SR; Feldman BM
J Popul Ther Clin Pharmacol; 2014; 21(1):e66-78. PubMed ID: 24671886
[TBL] [Abstract][Full Text] [Related]
9. Evidence-Based Medicine and Rare Diseases.
Day S
Adv Exp Med Biol; 2017; 1031():207-220. PubMed ID: 29214574
[TBL] [Abstract][Full Text] [Related]
10. Rare disease registries: potential applications towards impact on development of new drug treatments.
Jansen-van der Weide MC; Gaasterland CMW; Roes KCB; Pontes C; Vives R; Sancho A; Nikolakopoulos S; Vermeulen E; van der Lee JH
Orphanet J Rare Dis; 2018 Sep; 13(1):154. PubMed ID: 30185208
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of clinical trials in rare vs. common diseases: A register-based Latvian study.
Logviss K; Krievins D; Purvina S
PLoS One; 2018; 13(4):e0194494. PubMed ID: 29614103
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based medicine and rare diseases.
Day S
Adv Exp Med Biol; 2010; 686():41-53. PubMed ID: 20824438
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based medicine for rare diseases: implications for data interpretation and clinical trial design.
Behera M; Kumar A; Soares HP; Sokol L; Djulbegovic B
Cancer Control; 2007 Apr; 14(2):160-6. PubMed ID: 17387301
[TBL] [Abstract][Full Text] [Related]
14. Establishing Patient Registries for Rare Diseases: Rationale and Challenges.
Boulanger V; Schlemmer M; Rossov S; Seebald A; Gavin P
Pharmaceut Med; 2020 Jun; 34(3):185-190. PubMed ID: 32215853
[TBL] [Abstract][Full Text] [Related]
15. [Rare diseases in pulmonary medicine and its challenges].
Wencker M; Teschler H; Vogelmeier C; Koczulla R
Pneumologie; 2012 Jul; 66(7):437-41. PubMed ID: 22692970
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Rare Lung Diseases: The Challenges and Opportunities to Improve Research and Knowledge.
McCarthy C; Lara Gallego B; Trapnell BC; McCormack FX
Adv Exp Med Biol; 2017; 1031():419-442. PubMed ID: 29214586
[TBL] [Abstract][Full Text] [Related]
17. Methodology of clinical trials for rare diseases.
Tudur Smith C; Williamson PR; Beresford MW
Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):247-62. PubMed ID: 24974061
[TBL] [Abstract][Full Text] [Related]
18. Editorial of Special Issue "Rare Kidney Diseases: New Translational Research Approach to Improve Diagnosis and Therapy".
Zaza G; Gambaro G
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545922
[TBL] [Abstract][Full Text] [Related]
19. Towards efficiency in rare disease research: what is distinctive and important?
Jia J; Shi T
Sci China Life Sci; 2017 Jul; 60(7):686-691. PubMed ID: 28639105
[TBL] [Abstract][Full Text] [Related]
20. Rare Disease Registries Are Key to Evidence-Based Personalized Medicine: Highlighting the European Experience.
Kölker S; Gleich F; Mütze U; Opladen T
Front Endocrinol (Lausanne); 2022; 13():832063. PubMed ID: 35317224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
